PARIS--(BUSINESS WIRE)--TheraVectys, a biotechnology company that designs and develops lentiviral vector-based vaccines and immunotherapies against infectious agents and cancers, announces that the ...
Researchers from Purdue University and the U.S. Centers for Disease Control and Prevention have recently developed a novel influenza vaccine candidate that uses a bovine adenoviral (BAd) vector to ...
Vaccine strategies for the treatment of prostate cancer are under active investigation, using a wide variety of approaches including whole-tumor-cell vaccines, DC approaches and vector-driven delivery ...
News-Medical.Net on MSN
Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac
Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled ...
New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT). At the height of the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback